4//SEC Filing
ALDER BIOPHARMACEUTICALS INC 4
Accession 0001179110-15-012849
CIK 0001423824operating
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 2:51 PM ET
Size
5.8 KB
Accession
0001179110-15-012849
Insider Transaction Report
Form 4
DOW STEPHEN M
Director
Transactions
- Sale
Common Stock
2015-08-31$38.75/sh−16,218$628,460→ 282,278 total(indirect: See Footnote)
Footnotes (3)
- [F1]Represents 15,877 Common Shares sold directly by Sevin Rosen Fund IX L.P. and 341 Common Shares sold directly by Sevin Rosen IX Affiliates Fund L.P. pursuant to Rule 144 under the Securities Act of 1933, as amended.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at pricing ranging from $38.61 to $38.92 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Total Common Shares of 282,278 represents 88 shares owned by SRB Associates IX L.P. and 282,190 shares owned directly by The Dow Family Trust ("Dow Trust"). Reporting person is a member of the general partner of SRBAIX and disclaims beneficial ownership except to the extent of his proportionate interest in these shares. Reporting person is a trustee of the Dow Trust.
Documents
Issuer
ALDER BIOPHARMACEUTICALS INC
CIK 0001423824
Entity typeoperating
Related Parties
1- filerCIK 0001423824
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 2:51 PM ET
- Size
- 5.8 KB